• Certified Lab Equipment & Reagents
  • Fast Dispatch on In-Stock Items
  • Expert Scientific Support

Product details

IgM-Reducing Assay Diluent

Catalog number 625

Discontinued

Price for 625

Sign In for Pricing

Size / count 1 L

This variant is discontinued and cannot be added to your cart.

About this product

IgM-Reducing Assay Diluent is a specially formulated additive to address IgM-mediated conjugate bridging interference in problematic serum and plasma samples tested in antibody sandwich ELISA formats. IgM-Reducing Assay Diluent can be added to standard curve/calibrator and serum/plasma sample Wells to help equalize matrix complexity disparity issues.

Specifications

Catalog number
625
Size / count
1 L
Dry ice
No
Hazardous
No
Discontinued
Yes
Label
ICT
Type
ELISA & Assay Reagents
Assay Protocol
1. Once the capture antigen has been coated onto the plate and the plate has been properly blocked with one of ICT’s stabilizing blocker products, pipette 50 – 100 µL of Neptune Assay Diluent into each of the Wells of the ELISA plate using a multi-channel pipettor. The Assay Diluent is always added prior to adding the test and control serum/plasma samples to plate Wells., 2. The control and test samples should be diluted to the proper Well concentrations using one of ICT’s three different Sample Diluent products. Using an ICT Sample Diluent to dilute the serum and plasma samples will also serve to help minimize the degree of nonspecific IgG binding to the antigen coated and blocked ELISA plate Wells. The test (sera and plasma) samples, diluted typically to 1:40 or greater in a sample diluent should be incubated in the antigen-coated ELISA plates for 30 – 60 minutes at room temperature or 37°C.
Concentration
1X
pH
pH: 7.4 at 1X
Additionnal Information
ELISA & Assay Reagents ; Sample and Assay Diluents
Shipping Conditions
Ships overnight (domestic), International Priority Shipping
Storage Temperature
2-8°C
Shelf Life
Expires 18 months from date of manufacture
Target Description
IgM-Reducing Assay Diluent is an ELISA additive specially formulated for use with problematic serum and plasma samples tested in antibody sandwich ELISA formats. This diluent can be added to standard curve/calibrator and serum/plasma sample Wells to help equalize matrix complexity disparity issues., , Large differences in matrix complexity environment between standard curve and sample Wells are the main cause for target analyte under-recovery problems in sandwich ELISA analysis. Proprietary additives have been included in IgM-Reducing Assay Diluent to reduce IgM-mediated conjugate bridging interference that can otherwise cause substantial background noise., , IgM-Reducing Assay Diluent contains mammalian sera proteins to reduce nonspecific interactions that might occur between the sample matrix proteins and the plate surface. It also contains a proprietary calcium chelating agent designed to inhibit interference from complement and thrombin present in serum and plasma samples. An antimicrobial agent is included in the formulation to allow for bench-top use and storage stability., , Bulk volumes and custom packaging are available upon request.

Frequently Asked Questions

What is the catalog number for IgM-Reducing Assay Diluent?

The catalog number for IgM-Reducing Assay Diluent is 625.

Is IgM-Reducing Assay Diluent in stock?

IgM-Reducing Assay Diluent is currently made to order / not held in immediate stock. Contact us for lead time.

What is IgM-Reducing Assay Diluent used for?

IgM-Reducing Assay Diluent is a specially formulated additive to address IgM-mediated conjugate bridging interference in problematic serum and plasma samples tested in antibody sandwich ELISA formats. IgM-Reducing Assay Diluent can be added to standard curve/calibrator and serum/plasma sample Wells

What is the difference between this product and a similar catalogue number?

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Do you offer custom or private-label production of this type of product?

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

What is the immunogen used to generate this antibody?

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

You Might Also Like
CD7 (T3-3A1), CF405S conjugate, 0.1mg/mL
CD7 (T3-3A1), CF405S conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC040978-500
TGF-beta (1D11.16.8), CF647 conjugate, 0.1mg/mL
TGF-beta (1D11.16.8), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC470977-100
Cytokeratin, LMW (AE-1), CF640R conjugate, 0.1mg/mL
Cytokeratin, LMW (AE-1), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC400253-100
CD45RO (190-2F2.5), CF647 conjugate, 0.1mg/mL
CD45RO (190-2F2.5), CF647 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC471081-100
HSP27 (G3.1), CF740 conjugate, 0.1mg/mL
HSP27 (G3.1), CF740 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC740861-500
CD8 (C8/1035), CF568 conjugate, 0.1mg/mL
CD8 (C8/1035), CF568 conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC681035-500
CD31 / PECAM-1 (158-2B3), CF640R conjugate, 0.1mg/mL
CD31 / PECAM-1 (158-2B3), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC400352-100
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
TNF alpha (J2D10), CF640R conjugate, 0.1mg/mL
By Afraxis
Sign In for Pricing
Ref: BNC400994-100